Canada Pension Plan Investment Board Has Lowered Its Valeant Pharmaceuticals Intl Com (VRX) Position; Mueller Water Products (MWA)’s Sentiment Is 1.42

February 14, 2018 - By Hazel Jackson

Canada Pension Plan Investment Board decreased Valeant Pharmaceuticals Intl Com (VRX) stake by 98.04% reported in 2017Q3 SEC filing. Canada Pension Plan Investment Board sold 2.06M shares as Valeant Pharmaceuticals Intl Com (VRX)’s stock declined 15.71%. The Canada Pension Plan Investment Board holds 41,306 shares with $591,000 value, down from 2.10 million last quarter. Valeant Pharmaceuticals Intl Com now has $6.41 billion valuation. The stock increased 2.51% or $0.45 during the last trading session, reaching $18.4. About 2.09 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has declined 48.51% since February 14, 2017 and is downtrending. It has underperformed by 65.21% the S&P500.

Mueller Water Products, Inc. manufactures and markets services and products for the use in transmission, distribution, and measurement of water in the United States, Canada, and internationally. The company has market cap of $1.75 billion. The firm operates in three divisions: Mueller Co., Anvil, and Mueller Technologies. It has a 14.3 P/E ratio. The Mueller Co. segment offers valves for water and gas systems, including iron gate, butterfly, tapping, check, knife, plug, and ball valves; dry-barrel and wet-barrel fire hydrants; pipe repair products, such as clamps and couplings used to repair leaks under the Mueller and Jones brand names; small valves, meter bars, and line stopper fittings for use in gas systems; and machines and tools for tapping, drilling, extracting, installing, and stopping-off.

Analysts await Valeant Pharmaceuticals International, Inc. (NYSE:VRX) to report earnings on February, 27. They expect $0.97 EPS, down 23.02% or $0.29 from last year’s $1.26 per share. VRX’s profit will be $337.81 million for 4.74 P/E if the $0.97 EPS becomes a reality. After $1.04 actual EPS reported by Valeant Pharmaceuticals International, Inc. for the previous quarter, Wall Street now forecasts -6.73% negative EPS growth.

Investors sentiment decreased to 0.99 in Q3 2017. Its down 0.09, from 1.08 in 2017Q2. It dropped, as 43 investors sold VRX shares while 68 reduced holdings. 27 funds opened positions while 83 raised stakes. 169.87 million shares or 1.18% less from 171.89 million shares in 2017Q2 were reported. Comerica Savings Bank invested 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Benjamin F Edwards & Com stated it has 99 shares or 0% of all its holdings. Oakworth Inc invested 0% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Next Finance Gp holds 0.03% or 7,688 shares in its portfolio. Citadel Advsrs Ltd Llc accumulated 1.63 million shares. The Pennsylvania-based Vanguard Grp Inc has invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Blackrock owns 1.43M shares. Oppenheimer Inc, a New York-based fund reported 28,925 shares. Ls Investment Advsrs Limited Co owns 140 shares. Gabelli Funds Ltd Co holds 91,088 shares. Credit Suisse Ag holds 1.02M shares or 0.01% of its portfolio. Cornerstone Advsrs has 0% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 160 shares. Hightower Llc has 129,929 shares. Partners Ltd Liability Company reported 121,500 shares. Saba Mgmt Limited Partnership stated it has 1.35M shares or 1.96% of all its holdings.

Among 27 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 6 Sell and 15 Hold. Therefore 22% are positive. Valeant Pharmaceuticals Intl had 152 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by UBS on Friday, October 30. The stock has “Buy” rating by Nomura on Tuesday, September 29. The stock has “Buy” rating by Jefferies on Wednesday, June 8. On Wednesday, October 12 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The rating was maintained by Deutsche Bank with “Hold” on Monday, November 14. On Wednesday, November 9 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The rating was maintained by Jefferies with “Buy” on Wednesday, March 16. Scotia Capital maintained the shares of VRX in report on Tuesday, October 20 with “Sector Outperform” rating. The firm has “Market Perform” rating by BMO Capital Markets given on Wednesday, June 29. The firm earned “Buy” rating on Wednesday, September 13 by Jefferies.

Canada Pension Plan Investment Board increased Healthsouth Corp Com New (NYSE:HLS) stake by 148,300 shares to 244,000 valued at $11.31M in 2017Q3. It also upped Mettler Toledo International Com (NYSE:MTD) stake by 32,873 shares and now owns 45,500 shares. Phillips 66 Com (NYSE:PSX) was raised too.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>